Literature DB >> 25981358

Microalbuminuria and prediction of cardiovascular complications in patients with coronary artery disease and type 2 diabetes mellitus after CABG surgery.

Kristina S Shafranskaya1, Vasiliy V Kashtalap1, Anton G Kutikhin1, Olga L Barbarash2, Leonid S Barbarash1.   

Abstract

BACKGROUND: This investigation was aimed at assessing the clinical significance of microalbuminuria (MA) in predicting in-hospital adverse outcomes amongst the patients with coronary artery disease (CAD) and type 2 diabetes mellitus (DM) who have undergone coronary artery bypass graft (CABG) surgery.
METHODS: We recruited 720 consecutive Caucasian (Russian) patients who underwent CABG surgery during 2011-2012.
RESULTS: Patients with renal dysfunction (RD) and without type 2 DM had significantly higher median serum creatinine seven days after CABG surgery compared to patients without RD and type 2 DM. There were no statistically significant intergroup differences regarding glomerular filtration rate. However, the highest median of urine albumin excretion 24hours before and seven days after CABG surgery was detected in patients with RD and type 2 DM whilst the lowest median was noted in patients without RD and type 2 DM. Median of urine albumin excretion 24hours before and seven days after CABG surgery in patients with adverse outcome was significantly higher compared to patients with a favourable outcome.
CONCLUSIONS: We suggest that the determination of MA before and after CABG surgery may assist in predicting adverse outcomes after CABG surgery.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Adverse outcomes; Complications; Coronary artery bypass graft surgery; Coronary artery disease; EuroSCORE; Microalbuminuria

Mesh:

Substances:

Year:  2015        PMID: 25981358     DOI: 10.1016/j.hlc.2015.03.004

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  1 in total

1.  Metabolomics window into the role of acute kidney injury after coronary artery bypass grafting in diabetic nephropathy progression.

Authors:  Jiayi Wang; Wenzhe Yan; Xiang Zhou; Yu Liu; Chengyuan Tang; Youming Peng; Hong Liu; Lin Sun; Li Xiao; Liyu He
Journal:  PeerJ       Date:  2020-05-14       Impact factor: 2.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.